Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Pharmacoeconomics
|
July 26, 2014
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal
Nicholas R Latimer, Christopher Carroll, Ruth Wong, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 25, 2019
Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological Papers
Abualbishr Alshreef, Nicholas Latimer, Paul Tappenden, et al.
Pharmacoeconomics
|
December 13, 2016
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Lesley Uttley, Sophie Whyte, Timothy Gomersall, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
December 3, 2013
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
Lesley Uttley, Sue Harnan, Anna Cantrell, et al.
Pharmacoeconomics
|
December 17, 2013
The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis
Paul Tappenden, Sue Harnan, Lesley Uttley, et al.
Pharmacoeconomics
|
May 31, 2024
A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health Technologies
Paul Tappenden, Orla Hardiman, Sun-Hong Kwon, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 26, 2004
A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant
Myfanwy Lloyd Jones, Julie Wray, Jeremy Wight, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 26, 2004
The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative
Jim Chilcott, Paul Tappenden, Myfanwy Lloyd Jones, et al.
Pharmacoeconomics
|
March 8, 2020
A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway
Huajie Jin, Paul Tappenden, Stewart Robinson, et al.
Pharmacoeconomics
|
June 29, 2018
Ibrutinib for Treating Waldenström's Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Paul Tappenden, Christopher Carroll, John Stevens, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Pharmacoeconomics
|
July 26, 2014
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal
Nicholas R Latimer, Christopher Carroll, Ruth Wong, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 25, 2019
Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological Papers
Abualbishr Alshreef, Nicholas Latimer, Paul Tappenden, et al.
Pharmacoeconomics
|
December 13, 2016
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Lesley Uttley, Sophie Whyte, Timothy Gomersall, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
December 3, 2013
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
Lesley Uttley, Sue Harnan, Anna Cantrell, et al.
Pharmacoeconomics
|
December 17, 2013
The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis
Paul Tappenden, Sue Harnan, Lesley Uttley, et al.
Pharmacoeconomics
|
May 31, 2024
A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health Technologies
Paul Tappenden, Orla Hardiman, Sun-Hong Kwon, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 26, 2004
A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant
Myfanwy Lloyd Jones, Julie Wray, Jeremy Wight, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 26, 2004
The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative
Jim Chilcott, Paul Tappenden, Myfanwy Lloyd Jones, et al.
Pharmacoeconomics
|
March 8, 2020
A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway
Huajie Jin, Paul Tappenden, Stewart Robinson, et al.
Pharmacoeconomics
|
June 29, 2018
Ibrutinib for Treating Waldenström's Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Paul Tappenden, Christopher Carroll, John Stevens, et al.
Page
of 9